Recent Biotechnology Acquisitions in Minnesota
Acquisition Volume in Biotechnology in Minnesota by Year
Last 5 years
-
September 16, 2022
- Buyer
- Delwinds Insurance Acquisition Corp.
- Target
- FOXO Technologies Inc.
- Industry
- Biotechnology
- Location
- Minnesota, United States
- Type
- Buyout
FOXO Technologies Inc., a longevity-focused epigenetics and AI platform for the life insurance industry, completed a business combination with SPAC Delwinds Insurance Acquisition Corp., resulting in FOXO listing on the NYSE American under the ticker FOXO. The transaction positions FOXO to commercialize its molecular biomarkers and saliva-based underwriting protocols and to scale its FOXO Longevity Report and MGA distribution relationships.
-
March 31, 2021
- Buyer
- Vyant Bio, Inc. (formerly Cancer Genetics, Inc.)
- Target
- StemoniX, Inc.
- Seller
- Former holders of StemoniX common stock, preferred stock, convertible notes and certain warrants
- Industry
- Biotechnology
- Location
- Minnesota, United States
- Type
- Buyout
Cancer Genetics, Inc. completed a merger with StemoniX, Inc. and renamed the combined company Vyant Bio, Inc., with the new ticker VYNT on Nasdaq. StemoniX will operate as a wholly-owned subsidiary as the combined business integrates human iPSC-derived biology, software and preclinical capabilities to create a unified drug discovery platform.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.